Cost-effectiveness of Intensive Blood Pressure Management

JAMA cardiology

Volumn 1, Issue 8, 2016, Pages 872-879

  Richman, Ilana B ^a   Fairley, Michael ^b   Jørgensen, Mads Emil ^c   Schuler, Alejandro ^a   Owens, Douglas K ^a   Goldhaber Fiebert, Jeremy D ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Stanford University   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGED; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; COMPLICATION; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH CARE COST; HEART FAILURE; HUMAN; HYPERTENSION; QUALITY ADJUSTED LIFE YEAR;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HEART FAILURE; HUMANS; HYPERTENSION; QUALITY-ADJUSTED LIFE YEARS;

EID: 85009232817     PISSN: None     EISSN: 23806591     Source Type: Journal    
DOI: 10.1001/jamacardio.2016.3517     Document Type: Article

References (0)